TMX Newsfile

IN THE PRESS

Press Releases

Envoy Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

November 10, 2026

·

5 min read

Press Releases

OS Therapies Initiates U.K. MHRA Conditional Marketing Authorisation Application for Herlystic (OST-HER2) in the Prevention or Delay of Recurrence in Fully Resected, Pulmonary Metastatic Osteosarcoma

November 10, 2026

·

6 min read

Press Releases

TempraMed Granted U.S. Patent for Pen Agnostic, VIVI Cap Smart(TM) Further Strengthens Global Intellectual Property Position

November 10, 2026

·

5 min read

Press Releases

Lifordi Immunotherapeutics Presents Phase 1 Clinical Data for LFD-200, a Subcutaneous Glucocorticoid Antibody Drug Conjugate for Treatment of Autoimmune Disorders

November 9, 2026

·

2 min read

Press Releases

KALA BIO Provides CEO Update and Preliminary Third Quarter 2026 Financial Results

November 9, 2026

·

4 min read

Press Releases

Alenura Delivers Positive Phase 2 Results in Interstitial Cystitis/Bladder Pain Syndrome Trial

November 9, 2026

·

9 min read

Press Releases

Phio Pharmaceuticals Announces e-Presentation at American Society for Dermatologic Surgery (ASDS) Annual Meeting

November 9, 2026

·

4 min read

Press Releases

Telo Genomics Announces $250,000 Term Loan Facility

November 6, 2026

·

4 min read

Press Releases

Phio Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update as It Advances PH-762 Toward Phase 2b Study Initiation

November 5, 2026

·

10 min read

Press Releases

iSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI Products

November 5, 2026

·

6 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750